covid 19 News and Research

RSS

The impact of prior SARS-CoV-2 infection and vaccination on Omicron infection

researchers explored the effects of prior SARS-CoV-2 infection and vaccination on SARS-CoV-2 Omicron infection.

12 Jan 2023

BioGrad to open the UK's second largest biobank facility in Liverpool as part of a £7.6m investment into new headquarters

BioGrad is to open the UK's second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park.

From BioGrad 12 Jan 2023

Using lipid nanoparticles and messenger RNA to treat blindness associated with rare genetic condition

Oregon State University College of Pharmacy scientists have demonstrated in animal models the possibility of using lipid nanoparticles and messenger RNA, the technology underpinning COVID-19 vaccines, to treat blindness associated with a rare genetic condition.

11 Jan 2023

Annual or biannual boosters greatly reduce the long-term risk of infection from endemic COVID-19

While COVID-19 boosters have been found to protect against infection, hospitalization, and severe illness, the waning of their protection has led to uncertainty about when it is most appropriate to get an additional booster shot.

11 Jan 2023

Study shows booster vaccinations against SARS-CoV-2 effective but protection wanes rapidly

A recent study posted to medRxiv* assessed the effectiveness of primary and booster vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Netherlands.

11 Jan 2023

Bivalent boosters tested against all SARS-CoV-2 Omicron lineages

In a recent study posted to the bioRxiv* preprint server, researchers in the United States assessed the impact of the bivalent messenger ribonucleic acid (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine on the antibody-mediated neutralization of the SARS-CoV-2 Omicron lineages.

11 Jan 2023

COVID-19 outcomes in Rituximab treated patients

A new report throws light on SARS-CoV-2 breakthrough infections in patients with certain joint diseases or musculoskeletal conditions who are on rituximab and compares the severity of COVID-19 outcomes in these patients whilst identifying potential risk factors for severe outcomes.

11 Jan 2023

Most clergy embrace a medical understanding of depression’s etiology and treatment

A new Duke University study appears to ease concerns that clergy would steer congregants suffering from depression away from mental health providers and instead rely only on their faith.

11 Jan 2023

Did people use mental health services more during the COVID-19 pandemic?

Researchers explored the utilization rates of mental health services among adults during the coronavirus disease 2019 (COVID-19) pandemic.

11 Jan 2023

Researchers study congenital abnormalities after COVID-19 infection and vaccination

Researchers compared the significant congenital abnormalities observed after coronavirus disease 2019 (COVID-19) infection and vaccination.

11 Jan 2023

2022: a year in MIS-C research

In a recent review published in Nature Reviews Rheumatology, researchers reviewed existing data on the multisystem inflammatory syndrome in children (or MIS-C).

11 Jan 2023

Lifestyle and genetic factors influence risk of cardiovascular complications after COVID-19

Researchers examined the contribution of lifestyle and genetic factors to cardiovascular and thromboembolic event (CVE) risk following coronavirus disease 2019 (COVID-19).

11 Jan 2023

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

Researchers investigated the efficacy of a booster dose of the bivalent mRNA COVID-19 vaccine in preventing severe outcomes during SARS-CoV-2 infections.

11 Jan 2023

Review shows metformin usage to be associated with better COVID-19 outcomes

Researchers reported on the potential association between metformin usage and coronavirus disease 2019 (COVID-19) outcomes.

11 Jan 2023

Study suggests many symptoms are more common after COVID-19 infection, but only a few are commonly associated with a long COVID diagnosis

Researchers compared symptoms in patients with and without prior COVID-19 history and investigated symptoms associated with long COVID diagnosis in the UK.

11 Jan 2023

New analysis improves the scientific community's understanding of COVID-19 immunity

A new analysis by Cedars-Sinai investigators is furthering the scientific community's understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.

11 Jan 2023

MALAT1 suppression is a hallmark of tissue and peripheral proliferative T cells in COVID-19

In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom investigated lncRNA (long non-coding ribonucleic acids) expression in coronavirus disease 2019 (COVID-19) T lymphocyte transcriptomes.

10 Jan 2023

MIS-C more common and severe than previously thought

In a recent study published in the JAMA Network Open journal, researchers compared the characteristics of multisystem inflammatory syndrome in children (MIS-C) and coronavirus disease 2019 (COVID-19).

10 Jan 2023

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

University of North Florida Brooks College of Health faculty recently published a study showing dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates and can be an effective strategy to reduce the contagious respiratory disease burden during the winter.

10 Jan 2023

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

Researchers used electronic health records to characterize the incidence, biomarkers, attributes, and severity of SARS-CoV-2 reinfections and evaluated the association between reinfections and long coronavirus disease (COVID).

10 Jan 2023

covid 19 News and Research

The impact of prior SARS-CoV-2 infection and vaccination on Omicron infection

BioGrad to open the UK's second largest biobank facility in Liverpool as part of a £7.6m investment into new headquarters

Using lipid nanoparticles and messenger RNA to treat blindness associated with rare genetic condition

Annual or biannual boosters greatly reduce the long-term risk of infection from endemic COVID-19

Study shows booster vaccinations against SARS-CoV-2 effective but protection wanes rapidly

Bivalent boosters tested against all SARS-CoV-2 Omicron lineages

COVID-19 outcomes in Rituximab treated patients

Most clergy embrace a medical understanding of depression’s etiology and treatment

Did people use mental health services more during the COVID-19 pandemic?

Researchers study congenital abnormalities after COVID-19 infection and vaccination

2022: a year in MIS-C research

Lifestyle and genetic factors influence risk of cardiovascular complications after COVID-19

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

Review shows metformin usage to be associated with better COVID-19 outcomes

Study suggests many symptoms are more common after COVID-19 infection, but only a few are commonly associated with a long COVID diagnosis

New analysis improves the scientific community's understanding of COVID-19 immunity

MALAT1 suppression is a hallmark of tissue and peripheral proliferative T cells in COVID-19

MIS-C more common and severe than previously thought

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Latest News